By Stephen Nakrosis
FibroBiologics Inc. said Robert Hoffman, who is serving as interim chief financial officer, will step down at the close of business on May 14.
Hoffman, who is resigning to pursue another opportunity, will remain as a director on the company's board, FibroBiologics said Monday.
Hoffman was named interim CFO following the departure of CFO Mark Andersen, who resigned last year.
The company said it will initiate a search for a successor.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
May 05, 2025 18:51 ET (22:51 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.